{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:50:08Z","timestamp":1793332208382,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CM15\/00061"],"award-info":[{"award-number":["CM15\/00061"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["CB16\/12\/00401"],"award-info":[{"award-number":["CB16\/12\/00401"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["CIBERESP CB06\/02\/0073"],"award-info":[{"award-number":["CIBERESP CB06\/02\/0073"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI16\/01254"],"award-info":[{"award-number":["PI16\/01254"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["RD12\/0036\/0056"],"award-info":[{"award-number":["RD12\/0036\/0056"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2014SGR756"],"award-info":[{"award-number":["2014SGR756"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["MD088652"],"award-info":[{"award-number":["MD088652"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.bpobgyn.2017.08.015","type":"journal-article","created":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T13:50:04Z","timestamp":1504705804000},"page":"2-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":518,"special_numbering":"C","title":["The natural history of human papillomavirus infection"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5909-676X","authenticated-orcid":false,"given":"Silvia","family":"de Sanjos\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Brotons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Angel","family":"Pav\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bpobgyn.2017.08.015_bib1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","article-title":"Global burden of cancers attributable to infections in 2008: a review and synthetic analysis","volume":"13","author":"de Martel","year":"2012","journal-title":"Lancet Oncol"},{"issue":"Suppl. 8","key":"10.1016\/j.bpobgyn.2017.08.015_bib2","doi-asserted-by":"crossref","first-page":"I1","DOI":"10.1016\/j.vaccine.2013.07.026","article-title":"Comprehensive control of human papillomavirus infections and related diseases","volume":"31","author":"Bosch","year":"2013","journal-title":"Vaccine"},{"issue":"Suppl. 1","key":"10.1016\/j.bpobgyn.2017.08.015_bib3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/rmv.1822","article-title":"Human papillomavirus molecular biology and disease association","volume":"25","author":"Doorbar","year":"2015","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.bpobgyn.2017.08.015_bib4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s12879-016-1633-9","article-title":"The incidence, clearance and persistence of non-cervical human papillomavirus infections: a systematic review of the literature","volume":"16","author":"Taylor","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"12","key":"10.1016\/j.bpobgyn.2017.08.015_bib5","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1002\/ijc.29082","article-title":"EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection","volume":"136","author":"Giuliano","year":"2015","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.015_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","article-title":"Classification of papillomaviruses","volume":"324","author":"de Villiers","year":"2004","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.015_bib7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.virol.2010.02.002","article-title":"Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments","volume":"401","author":"Bernard","year":"2010","journal-title":"Virology"},{"issue":"1\u20132","key":"10.1016\/j.bpobgyn.2017.08.015_bib8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.virol.2013.04.023","article-title":"Cross-roads in the classification of papillomaviruses","volume":"445","author":"de Villiers","year":"2013","journal-title":"Virology"},{"issue":"Suppl. 5","key":"10.1016\/j.bpobgyn.2017.08.015_bib9","doi-asserted-by":"crossref","first-page":"F55","DOI":"10.1016\/j.vaccine.2012.06.083","article-title":"The biology and life-cycle of human papillomaviruses","volume":"30","author":"Doorbar","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.bpobgyn.2017.08.015_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.virusres.2016.12.017","article-title":"The low-risk papillomaviruses","volume":"231","author":"Egawa","year":"2017","journal-title":"Virus Res"},{"key":"10.1016\/j.bpobgyn.2017.08.015_bib11","first-page":"1","volume":"vol. 90","author":"IARC","year":"2007"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.015_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/emph\/eov003","article-title":"Papillomaviruses: viral evolution, cancer and evolutionary medicine","volume":"2015","author":"Bravo","year":"2015","journal-title":"Evol Med Public Health"},{"issue":"6","key":"10.1016\/j.bpobgyn.2017.08.015_bib13","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1006\/scbi.1999.0141","article-title":"Human papillomavirus life cycle: active and latent phases","volume":"9","author":"Stubenrauch","year":"1999","journal-title":"Semin Cancer Biol"},{"issue":"7","key":"10.1016\/j.bpobgyn.2017.08.015_bib14","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.3390\/v7072802","article-title":"Human papillomaviruses; epithelial tropisms, and the development of neoplasia","volume":"7","author":"Egawa","year":"2015","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.bpobgyn.2017.08.015_bib15","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/modpathol.2015.54","article-title":"Microanatomy of the cervical and anorectal squamocolumnar junctions: a proposed model for anatomical differences in HPV-related cancer risk","volume":"28","author":"Yang","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.bpobgyn.2017.08.015_bib16","doi-asserted-by":"crossref","first-page":"16086","DOI":"10.1038\/nrdp.2016.86","article-title":"Carcinogenic human papillomavirus infection","volume":"2","author":"Schiffman","year":"2016","journal-title":"Nat Rev Dis Prim"},{"issue":"Suppl. 5","key":"10.1016\/j.bpobgyn.2017.08.015_bib17","doi-asserted-by":"crossref","first-page":"F83","DOI":"10.1016\/j.vaccine.2012.04.106","article-title":"Human papillomavirus vaccines\u2013immune responses","volume":"30","author":"Stanley","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.015_bib18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/156800907780006869","article-title":"Mechanisms used by human papillomaviruses to escape the host immune response","volume":"7","author":"Kanodia","year":"2007","journal-title":"Curr Cancer Drug Targets"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.015_bib19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ncponc0984","article-title":"Human papillomavirus in cervical and head-and-neck cancer","volume":"5","author":"Psyrri","year":"2008","journal-title":"Nat Clin Pract Oncol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2017.08.015_bib20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bbadis.2007.12.005","article-title":"Viruses associated with human cancer","volume":"1782","author":"McLaughlin-Drubin","year":"2008","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"10.1016\/j.bpobgyn.2017.08.015_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006211","article-title":"The role of integration in oncogenic progression of HPV-associated cancers","volume":"13","author":"McBride","year":"2017","journal-title":"PLoS Pathog"},{"issue":"7645","key":"10.1016\/j.bpobgyn.2017.08.015_bib22","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nature21386","article-title":"Integrated genomic and molecular characterization of cervical cancer","volume":"543","author":"Cancer Genome Atlas Research Network","year":"2017","journal-title":"Nature"},{"issue":"7536","key":"10.1016\/j.bpobgyn.2017.08.015_bib23","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nature14129","article-title":"Comprehensive genomic characterization of head and neck squamous cell carcinomas","volume":"517","author":"Cancer Genome Atlas Research Network","year":"2015","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bpobgyn.2017.08.015_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02234-14","article-title":"Human papillomavirus E6 triggers upregulation of the antiviral and cancer genomic DNA deaminase APOBEC3B","volume":"5","author":"Vieira","year":"2014","journal-title":"MBio"},{"issue":"2","key":"10.1016\/j.bpobgyn.2017.08.015_bib25","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1128\/JVI.03091-13","article-title":"APOBEC3 deaminases induce hypermutation in human papillomavirus 16 DNA upon beta interferon stimulation","volume":"88","author":"Wang","year":"2014","journal-title":"J\u00a0Virol"},{"issue":"9","key":"10.1016\/j.bpobgyn.2017.08.015_bib26","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/ng.2702","article-title":"An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers","volume":"45","author":"Roberts","year":"2013","journal-title":"Nat Genet"},{"issue":"1\u20132","key":"10.1016\/j.bpobgyn.2017.08.015_bib27","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.virol.2013.07.018","article-title":"Human papillomavirus genome variants","volume":"445","author":"Burk","year":"2013","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.bpobgyn.2017.08.015_bib28","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw100","article-title":"HPV16 sublineage associations with histology-specific cancer risk using HPV whole-genome sequences in 3200 women","volume":"108","author":"Mirabello","year":"2016","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.bpobgyn.2017.08.015_bib29","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1158\/1055-9965.EPI-12-0905","article-title":"Human papillomavirus DNA methylation as a potential biomarker for cervical cancer","volume":"21","author":"Clarke","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"14","key":"10.1016\/j.bpobgyn.2017.08.015_bib30","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1158\/1078-0432.CCR-16-2641","article-title":"Genome-wide DNA methylation profiling reveals methylation markers associated with 3q gain for detection of cervical precancer and cancer","volume":"23","author":"Verlaat","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.bpobgyn.2017.08.015_bib31","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings","volume":"202","author":"Bruni","year":"2010","journal-title":"J\u00a0Infect Dis"},{"issue":"2","key":"10.1016\/j.bpobgyn.2017.08.015_bib32","first-page":"101","article-title":"High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse)","volume":"10","author":"Kjaer","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"10.1016\/j.bpobgyn.2017.08.015_bib33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1086\/524875","article-title":"Risk of female human papillomavirus acquisition associated with first male sex partner","volume":"197","author":"Winer","year":"2008","journal-title":"J\u00a0Infect Dis"},{"issue":"8","key":"10.1016\/j.bpobgyn.2017.08.015_bib34","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1158\/1055-9965.EPI-10-0394","article-title":"The role of sexual behavior and human papillomavirus persistence in predicting repeated infections with new human papillomavirus types","volume":"19","author":"Moscicki","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bpobgyn.2017.08.015_bib35","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.pvr.2017.03.003","article-title":"Effect of age-difference between heterosexual partners on risk of cervical cancer and human papillomavirus infection","volume":"3","author":"Baussano","year":"2017","journal-title":"Papillomavirus Res"},{"issue":"12","key":"10.1016\/j.bpobgyn.2017.08.015_bib36","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1086\/425907","article-title":"Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results","volume":"190","author":"Mu\u00f1oz","year":"2004","journal-title":"J\u00a0Infect Dis"},{"issue":"7","key":"10.1016\/j.bpobgyn.2017.08.015_bib37","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/sj.bjc.6604972","article-title":"Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women","volume":"100","author":"Mu\u00f1oz","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bpobgyn.2017.08.015_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e4168","article-title":"Frequency and risk factors for prevalent, incident, and persistent genital carcinogenic human papillomavirus infection in sexually active women: community based cohort study","volume":"344","author":"Oakeshott","year":"2012","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.bpobgyn.2017.08.015_bib39","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/infdis\/jiw074","article-title":"Incident detection of high-risk human papillomavirus infections in a cohort of high-risk women aged 25-65 years","volume":"214","author":"Winer","year":"2016","journal-title":"J\u00a0Infect Dis"},{"issue":"11","key":"10.1016\/j.bpobgyn.2017.08.015_bib40","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/jmv.24891","article-title":"Incidence and risk factors for human papillomavirus infections in young female online daters","volume":"89","author":"Ma","year":"2017","journal-title":"J\u00a0Med Virol"},{"issue":"8","key":"10.1016\/j.bpobgyn.2017.08.015_bib41","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011371","article-title":"Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-na\u00efve women: results from the control arm of a phase II HPV-16\/18 vaccine trial","volume":"6","author":"Ramanakumar","year":"2016","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.bpobgyn.2017.08.015_bib42","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/jnci\/djq001","article-title":"Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2\/3: critical role of duration of infection","volume":"102","author":"Rodr\u00edguez","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.bpobgyn.2017.08.015_bib43","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1158\/1055-9965.EPI-10-1108","article-title":"Early natural history of incident, type-specific human papillomavirus infections in newly sexually active young women","volume":"20","author":"Winer","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"10.1016\/j.bpobgyn.2017.08.015_bib44","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1128\/CDLI.6.5.751-755.1999","article-title":"Th1 cytokine patterns in cervical human papillomavirus infection","volume":"6","author":"Scott","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2017.08.015_bib45","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/mi.2016.129","article-title":"Association of HPV infection and clearance with cervicovaginal immunology and the vaginal microbiota","volume":"10","author":"Shannon","year":"2017","journal-title":"Mucosal Immunol"},{"issue":"11","key":"10.1016\/j.bpobgyn.2017.08.015_bib46","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/infdis\/jiu330","article-title":"Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection","volume":"210","author":"Brotman","year":"2014","journal-title":"J\u00a0Infect Dis"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.015_bib47","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1017\/S0950268815000965","article-title":"Prevalent high-risk HPV infection and vaginal microbiota in Nigerian women","volume":"144","author":"Dareng","year":"2016","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.bpobgyn.2017.08.015_bib48","doi-asserted-by":"crossref","DOI":"10.1007\/s10096-017-3048-y","article-title":"Association of asymptomatic bacterial vaginosis with persistence of female genital human papillomavirus infection","author":"Kero","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"10","key":"10.1016\/j.bpobgyn.2017.08.015_bib49","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1086\/344354","article-title":"Seroprevalence of human papillomavirus type 16 infection in the United States","volume":"186","author":"Stone","year":"2002","journal-title":"J\u00a0Infect Dis"},{"issue":"9","key":"10.1016\/j.bpobgyn.2017.08.015_bib50","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1093\/infdis\/jiv753","article-title":"Natural acquired immunity against subsequent genital human papillomavirus infection: a systematic review and meta-analysis","volume":"213","author":"Beachler","year":"2016","journal-title":"J\u00a0Infect Dis"},{"issue":"19","key":"10.1016\/j.bpobgyn.2017.08.015_bib51","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","author":"Future II Study Group","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"9686","key":"10.1016\/j.bpobgyn.2017.08.015_bib52","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2017.08.015_bib53","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jcv.2017.03.002","article-title":"Effect of naturally acquired type-specific serum antibodies against human papillomavirus type 16 infection","volume":"90","author":"Triglav","year":"2017","journal-title":"J Clin Virol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.015_bib54","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1128\/JVI.02589-13","article-title":"Immunosuppression facilitates the reactivation of latent papillomavirus infections","volume":"88","author":"Maglennon","year":"2014","journal-title":"J\u00a0Virol"},{"issue":"9916","key":"10.1016\/j.bpobgyn.2017.08.015_bib55","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.bpobgyn.2017.08.015_bib56","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/dji187","article-title":"The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice","volume":"97","author":"Khan","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.bpobgyn.2017.08.015_bib57","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1128\/JCM.05979-11","article-title":"Evaluation of any or type-specific persistence of high-risk human papillomavirus for detecting cervical precancer","volume":"50","author":"Marks","year":"2012","journal-title":"J\u00a0Clin Microbiol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2017.08.015_bib58","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/infdis\/jiq116","article-title":"Long-term persistence of prevalently detected human papillomavirus infections in the absence of detectable cervical precancer and cancer","volume":"203","author":"Castle","year":"2011","journal-title":"J\u00a0Infect Dis"},{"issue":"6","key":"10.1016\/j.bpobgyn.2017.08.015_bib59","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/infdis\/jiq131","article-title":"Persistence of concurrent infections with multiple human papillomavirus types: a population-based cohort study","volume":"203","author":"Campos","year":"2011","journal-title":"J\u00a0Infect Dis"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.015_bib60","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc2050","article-title":"The natural history of cervical HPV infection: unresolved issues","volume":"7","author":"Woodman","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"19","key":"10.1016\/j.bpobgyn.2017.08.015_bib61","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00844-17","article-title":"Whole-genome sequencing and variant analysis of hpv16 infections","volume":"91","author":"Van der Weele","year":"2017","journal-title":"J\u00a0Virol"},{"issue":"11","key":"10.1016\/j.bpobgyn.2017.08.015_bib62","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Retrospective International Survey and HPV Time Trends Study Group. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"issue":"16","key":"10.1016\/j.bpobgyn.2017.08.015_bib63","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1016\/j.ejca.2013.06.033","article-title":"Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva","volume":"49","author":"de Sanjos\u00e9","year":"2013","journal-title":"Eur J Cancer"},{"issue":"16","key":"10.1016\/j.bpobgyn.2017.08.015_bib64","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1016\/j.ejca.2014.07.018","article-title":"Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples","volume":"50","author":"Alemany","year":"2014","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.015_bib65","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ijc.28963","article-title":"Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide","volume":"136","author":"Alemany","year":"2015","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.bpobgyn.2017.08.015_bib66","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.eururo.2015.12.007","article-title":"Role of human papillomavirus in penile carcinomas worldwide","volume":"69","author":"Alemany","year":"2016","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2017.08.015_bib67","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3322\/caac.21139","article-title":"American cancer society, American society for colposcopy and cervical pathology, and American society for clinical pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"62","author":"Saslow","year":"2012","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10.1016\/j.bpobgyn.2017.08.015_bib68","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/ijc.21953","article-title":"Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies","volume":"119","author":"International Collaboration of Epidemiological Studies of Cervical Cancer","year":"2006","journal-title":"Int J Cancer"},{"issue":"9599","key":"10.1016\/j.bpobgyn.2017.08.015_bib69","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0140-6736(07)61684-5","article-title":"Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies","volume":"370","author":"Appleby","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bpobgyn.2017.08.015_bib70","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0168-1702(02)00188-0","article-title":"Environmental co-factors in HPV carcinogenesis","volume":"89","author":"Castellsagu\u00e9","year":"2002","journal-title":"Virus Res"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.015_bib71","doi-asserted-by":"crossref","first-page":"e0147029","DOI":"10.1371\/journal.pone.0147029","article-title":"The influence of hormonal factors on the risk of developing cervical cancer and pre-cancer: results from the EPIC cohort","volume":"11","author":"Roura","year":"2016","journal-title":"PLoS One"},{"issue":"23","key":"10.1016\/j.bpobgyn.2017.08.015_bib72","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/jnci\/djq436","article-title":"Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort","volume":"102","author":"Safaeian","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"13","key":"10.1016\/j.bpobgyn.2017.08.015_bib73","article-title":"Chlamydia trachomatis infection-associated risk of cervical cancer: a meta-analysis","volume":"95","author":"H","year":"2016","journal-title":"Med (Balt)"},{"issue":"4","key":"10.1016\/j.bpobgyn.2017.08.015_bib74","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s13669-015-0132-0","article-title":"Concomitant infection of HIV and HPV: what are the consequences?","volume":"4","author":"Kelly","year":"2015","journal-title":"Curr Obstet Gynecol Rep"},{"key":"10.1016\/j.bpobgyn.2017.08.015_bib75","article-title":"Antiretroviral therapy, high-risk human papillomavirus, cervical intraepithelial neoplasia and invasive cervical cancer: a systematic review and meta-analysis","author":"Kelly","year":"2017","journal-title":"The Lancet HIV"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693417301335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693417301335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T23:14:13Z","timestamp":1657667653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693417301335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":75,"alternative-id":["S1521693417301335"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2017.08.015","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The natural history of human papillomavirus infection","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2017.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}